Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 7
2021 5
2022 2
2023 3
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial.
Quenby S, Booth K, Hiller L, Coomarasamy A, de Jong PG, Hamulyák EN, Scheres LJ, van Haaps TF, Ewington L, Tewary S, Goddijn M, Middeldorp S; ALIFE2 Block Writing Committee; ALIFE2 Investigators. Quenby S, et al. Among authors: hamulyak en. Lancet. 2023 Jul 1;402(10395):54-61. doi: 10.1016/S0140-6736(23)00693-1. Epub 2023 Jun 1. Lancet. 2023. PMID: 37271152 Clinical Trial.
Management of anticoagulation in patients with brain metastasis.
Hamulyák EN, Yust-Katz S, Leader A. Hamulyák EN, et al. Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):246-252. doi: 10.1182/hematology.2024000660. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644055 Free PMC article. Review.
Progress of the ALIFE2 study: A dynamic road towards more evidence.
Hamulyák EN, de Jong PG, Scheres LJJ, Ewington LJ, Middeldorp S, Quenby S, Goddijn M. Hamulyák EN, et al. Thromb Res. 2020 Jun;190:39-44. doi: 10.1016/j.thromres.2020.03.015. Epub 2020 Mar 18. Thromb Res. 2020. PMID: 32298839 Free article. Review.
Venous thromboembolism among physically active young adult females.
Shapiro M, Hamulyák EN, Leader A, Landau R, Middeldorp S, Gurevich-Shapiro A. Shapiro M, et al. Among authors: hamulyak en. Res Pract Thromb Haemost. 2023 Oct 20;7(8):102236. doi: 10.1016/j.rpth.2023.102236. eCollection 2023 Nov. Res Pract Thromb Haemost. 2023. PMID: 38193067 Free PMC article.
Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial.
Hamulyák EN, Wiegers HMG, Hutten BA, de Lange ME, Timmermans A, Westerweel PE, Nijziel MR, Klok FA, Hovens MM, Kamphuisen PW, Büller HR, Middeldorp S, Scheres LJJ. Hamulyák EN, et al. Res Pract Thromb Haemost. 2024 May 20;8(4):102448. doi: 10.1016/j.rpth.2024.102448. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38953049 Free PMC article. No abstract available.
18 results